HEADER HYDROLASE/HYDROLASE INHIBITOR 14-NOV-03 1RHQ
TITLE CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A
TITLE 2 BROMOMETHOXYPHENYL INHIBITOR
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: CASPASE-3;
COMPND 3 CHAIN: A, D;
COMPND 4 FRAGMENT: P17 SUBUNIT;
COMPND 5 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN,
COMPND 6 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1;
COMPND 7 EC: 3.4.22.-;
COMPND 8 ENGINEERED: YES;
COMPND 9 MOL_ID: 2;
COMPND 10 MOLECULE: CASPASE-3;
COMPND 11 CHAIN: B, E;
COMPND 12 FRAGMENT: P12 SUBUNIT;
COMPND 13 SYNONYM: CYSTEINE PROTEASE CPP32, YAMA PROTEIN, CPP-32, APOPAIN,
COMPND 14 CASP-3, SREBP CLEAVAGE ACTIVITY 1, SCA-1;
COMPND 15 EC: 3.4.22.-;
COMPND 16 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: CASP3, CPP32;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 MOL_ID: 2;
SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 12 ORGANISM_COMMON: HUMAN;
SOURCE 13 ORGANISM_TAXID: 9606;
SOURCE 14 GENE: CASP3, CPP32;
SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3);
SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008;
SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 18 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID
KEYWDS CYSTEINE PROTEASE, CASPASE-3, APOPAIN, CPP32, YAMA, HYDROLASE-
KEYWDS 2 HYDROLASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.W.BECKER,J.ROTONDA,S.M.SOISSON
REVDAT 10 20-NOV-24 1RHQ 1 REMARK
REVDAT 9 13-MAR-24 1RHQ 1 COMPND SOURCE
REVDAT 8 20-SEP-23 1RHQ 1 REMARK
REVDAT 7 21-DEC-22 1RHQ 1 REMARK SEQADV LINK
REVDAT 6 11-OCT-17 1RHQ 1 REMARK
REVDAT 5 22-JAN-14 1RHQ 1 MTRIX1 MTRIX2 MTRIX3
REVDAT 4 13-JUL-11 1RHQ 1 VERSN
REVDAT 3 12-MAY-09 1RHQ 1 MTRIX1 MTRIX2 MTRIX3
REVDAT 2 24-FEB-09 1RHQ 1 VERSN
REVDAT 1 11-MAY-04 1RHQ 0
JRNL AUTH J.W.BECKER,J.ROTONDA,S.M.SOISSON,R.ASPIOTIS,C.BAYLY,
JRNL AUTH 2 S.FRANCOEUR,M.GALLANT,M.GARCIA-CALVO,A.GIROUX,E.GRIMM,Y.HAN,
JRNL AUTH 3 D.MCKAY,D.W.NICHOLSON,E.PETERSON,J.RENAUD,S.ROY,
JRNL AUTH 4 N.THORNBERRY,R.ZAMBONI
JRNL TITL REDUCING THE PEPTIDYL FEATURES OF CASPASE-3 INHIBITORS: A
JRNL TITL 2 STRUCTURAL ANALYSIS.
JRNL REF J.MED.CHEM. V. 47 2466 2004
JRNL REFN ISSN 0022-2623
JRNL PMID 15115390
JRNL DOI 10.1021/JM0305523
REMARK 2
REMARK 2 RESOLUTION. 3.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2002
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 19655.730
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 84.4
REMARK 3 NUMBER OF REFLECTIONS : 9964
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.273
REMARK 3 R VALUE (WORKING SET) : 0.273
REMARK 3 FREE R VALUE : 0.354
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200
REMARK 3 FREE R VALUE TEST SET COUNT : 1020
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 9964
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.19
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.70
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1312
REMARK 3 BIN R VALUE (WORKING SET) : 0.3490
REMARK 3 BIN FREE R VALUE : 0.4110
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.10
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.036
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3740
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 72
REMARK 3 SOLVENT ATOMS : 0
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 11.80
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 6.56000
REMARK 3 B22 (A**2) : 2.42000
REMARK 3 B33 (A**2) : -8.97000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 4.48000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.45
REMARK 3 ESD FROM SIGMAA (A) : 0.62
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.62
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.75
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 1.600
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.20
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 6.100 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 9.470 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 7.300 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 10.780; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.18
REMARK 3 BSOL : 10.00
REMARK 3
REMARK 3 NCS MODEL : CONSTR
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P
REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : PARAM.ICE
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : TOP_NEW.ICE
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4
REMARK 4 1RHQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-NOV-03.
REMARK 100 THE DEPOSITION ID IS D_1000020752.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 05-APR-98
REMARK 200 TEMPERATURE (KELVIN) : 293
REMARK 200 PH : 4.93
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178
REMARK 200 MONOCHROMATOR : GRAPHITE
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : AREA DETECTOR
REMARK 200 DETECTOR MANUFACTURER : SIEMENS
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : X-GEN
REMARK 200 DATA SCALING SOFTWARE : SAINT V. 4.050
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11487
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.999
REMARK 200 RESOLUTION RANGE LOW (A) : 20.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 96.8
REMARK 200 DATA REDUNDANCY : 1.390
REMARK 200 R MERGE (I) : 0.06100
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.2200
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.11
REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7
REMARK 200 DATA REDUNDANCY IN SHELL : 1.20
REMARK 200 R MERGE FOR SHELL (I) : 0.16300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.030
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: X-PLOR
REMARK 200 STARTING MODEL: PROTEIN PART OF 1PAU.PDB
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 52.48
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 7.8% PEG-6000, 100 MM CITRATE, 120 MM
REMARK 280 ZNCL(2), 10 MM DTT, 3 MM NAN(3), PH 4.93, VAPOR DIFFUSION,
REMARK 280 HANGING DROP, TEMPERATURE 293K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y,-Z
REMARK 290 3555 X+1/2,Y+1/2,Z
REMARK 290 4555 -X+1/2,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 55.15000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.45000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 55.15000
REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 48.45000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 13370 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 17670 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -74.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, D, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 SER A 145
REMARK 465 GLY A 146
REMARK 465 ILE A 147
REMARK 465 SER A 148
REMARK 465 LEU A 149
REMARK 465 THR A 296
REMARK 465 ASP A 297
REMARK 465 SER B 310
REMARK 465 GLY B 311
REMARK 465 VAL B 312
REMARK 465 ASP B 313
REMARK 465 ASP B 314
REMARK 465 ASP B 315
REMARK 465 MET B 316
REMARK 465 ALA B 317
REMARK 465 CYS B 318
REMARK 465 HIS B 319
REMARK 465 HIS B 402
REMARK 465 SER D 145
REMARK 465 GLY D 146
REMARK 465 ILE D 147
REMARK 465 SER D 148
REMARK 465 LEU D 149
REMARK 465 THR D 296
REMARK 465 ASP D 297
REMARK 465 SER E 310
REMARK 465 GLY E 311
REMARK 465 VAL E 312
REMARK 465 ASP E 313
REMARK 465 ASP E 314
REMARK 465 ASP E 315
REMARK 465 MET E 316
REMARK 465 ALA E 317
REMARK 465 CYS E 318
REMARK 465 HIS E 319
REMARK 465 HIS E 402
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 OE2 GLU A 239 OE2 GLU A 239 2758 0.72
REMARK 500 NE2 HIS D 174 OD1 ASP E 381E 2758 1.49
REMARK 500 O GLY A 175C O GLY A 175C 2758 1.54
REMARK 500 CA GLY A 175C CG2 THR A 177 2758 1.83
REMARK 500 CD GLU A 239 OE2 GLU A 239 2758 1.92
REMARK 500 CE1 HIS D 174 OD1 ASP E 381E 2758 1.98
REMARK 500 NE2 HIS D 174 CG ASP E 381E 2758 2.18
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ASP A 156 42.68 -157.62
REMARK 500 PRO A 161 -13.33 -48.51
REMARK 500 LYS A 171 -44.33 -149.51
REMARK 500 ARG A 179 79.64 -105.66
REMARK 500 SER A 180 93.48 -58.01
REMARK 500 ASP A 185 -85.45 -52.64
REMARK 500 ALA A 186 -35.80 -27.34
REMARK 500 ASP A 205 63.01 25.72
REMARK 500 GLU A 209 39.38 -83.89
REMARK 500 GLU A 210 -42.62 -142.70
REMARK 500 MET A 215 -70.90 -53.45
REMARK 500 SER A 229 -173.72 177.79
REMARK 500 SER A 236 -159.13 179.76
REMARK 500 HIS A 237 -168.62 -109.75
REMARK 500 ILE A 243 126.40 -172.62
REMARK 500 THR A 246 30.26 -84.64
REMARK 500 ASN A 247 -34.96 -149.38
REMARK 500 LYS A 260 10.78 -66.58
REMARK 500 PHE A 264 -3.83 -57.95
REMARK 500 ARG A 269 -75.34 -76.24
REMARK 500 THR A 288 37.63 -146.94
REMARK 500 ASP B 326 12.40 81.66
REMARK 500 SER B 343 -9.58 -55.43
REMARK 500 LYS B 344 -72.54 -114.35
REMARK 500 SER B 347 133.61 -37.67
REMARK 500 TRP B 348 -74.38 -50.10
REMARK 500 ALA B 361 8.32 -56.31
REMARK 500 ASP B 362 15.82 -141.69
REMARK 500 GLU B 365 -108.60 -92.14
REMARK 500 PHE B 366 -49.67 -154.19
REMARK 500 LYS B 376 13.61 -68.40
REMARK 500 ALA B 382 52.28 75.06
REMARK 500 PHE B 400 71.00 -63.01
REMARK 500 ASP D 156 42.63 -157.65
REMARK 500 PRO D 161 -13.30 -48.56
REMARK 500 LYS D 171 -44.36 -149.49
REMARK 500 ARG D 179 79.65 -105.65
REMARK 500 SER D 180 93.46 -57.97
REMARK 500 ASP D 185 -85.47 -52.62
REMARK 500 ALA D 186 -35.76 -27.37
REMARK 500 ASP D 205 63.00 25.72
REMARK 500 GLU D 209 39.43 -83.91
REMARK 500 GLU D 210 -42.60 -142.74
REMARK 500 MET D 215 -70.83 -53.49
REMARK 500 SER D 229 -173.69 177.82
REMARK 500 SER D 236 -159.12 179.77
REMARK 500 HIS D 237 -168.63 -109.76
REMARK 500 ILE D 243 126.44 -172.63
REMARK 500 THR D 246 30.25 -84.58
REMARK 500 ASN D 247 -35.00 -149.35
REMARK 500
REMARK 500 THIS ENTRY HAS 66 RAMACHANDRAN OUTLIERS.
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THE INHIBITOR BINDS TO THE CATALYTIC CYS 285 IN CHAINS
REMARK 600 A AND D VIA HEMITHIOACETAL LINKAGES
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: 5-S-BENZYL-3-({N-[(5-BROMO-2-METHOXYPHENYL)ACETYL]-
REMARK 630 L-VALYL}AMINO)-2,3-DIDEOXY-5-THIO-D-ERYTHRO-PENTONIC ACID
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0ZZ A 551
REMARK 630 0ZZ D 551
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: IRA VAL RH0
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZZ A 551
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0ZZ D 551
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1PAU RELATED DB: PDB
REMARK 900 CASPASE-3 COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP-ALDEHYDE
REMARK 900 RELATED ID: 1RHJ RELATED DB: PDB
REMARK 900 RELATED ID: 1RHK RELATED DB: PDB
REMARK 900 RELATED ID: 1RHM RELATED DB: PDB
REMARK 900 RELATED ID: 1RHR RELATED DB: PDB
REMARK 900 RELATED ID: 1RHU RELATED DB: PDB
DBREF 1RHQ A 145 297 UNP P42574 ICE3_HUMAN 29 175
DBREF 1RHQ D 145 297 UNP P42574 ICE3_HUMAN 29 175
DBREF 1RHQ B 310 402 UNP P42574 ICE3_HUMAN 176 277
DBREF 1RHQ E 310 402 UNP P42574 ICE3_HUMAN 176 277
SEQADV 1RHQ GLU B 324 UNP P42574 ASP 190 VARIANT
SEQADV 1RHQ GLU E 324 UNP P42574 ASP 190 VARIANT
SEQRES 1 A 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR
SEQRES 2 A 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN
SEQRES 3 A 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR
SEQRES 4 A 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN
SEQRES 5 A 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG
SEQRES 6 A 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU
SEQRES 7 A 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU
SEQRES 8 A 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY
SEQRES 9 A 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY
SEQRES 10 A 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE
SEQRES 11 A 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY
SEQRES 12 A 147 ILE GLU THR ASP
SEQRES 1 B 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO
SEQRES 2 B 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO
SEQRES 3 B 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP
SEQRES 4 B 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA
SEQRES 5 B 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN
SEQRES 6 B 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP
SEQRES 7 B 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL
SEQRES 8 B 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS
SEQRES 1 D 147 SER GLY ILE SER LEU ASP ASN SER TYR LYS MET ASP TYR
SEQRES 2 D 147 PRO GLU MET GLY LEU CYS ILE ILE ILE ASN ASN LYS ASN
SEQRES 3 D 147 PHE HIS LYS SER THR GLY MET THR SER ARG SER GLY THR
SEQRES 4 D 147 ASP VAL ASP ALA ALA ASN LEU ARG GLU THR PHE ARG ASN
SEQRES 5 D 147 LEU LYS TYR GLU VAL ARG ASN LYS ASN ASP LEU THR ARG
SEQRES 6 D 147 GLU GLU ILE VAL GLU LEU MET ARG ASP VAL SER LYS GLU
SEQRES 7 D 147 ASP HIS SER LYS ARG SER SER PHE VAL CYS VAL LEU LEU
SEQRES 8 D 147 SER HIS GLY GLU GLU GLY ILE ILE PHE GLY THR ASN GLY
SEQRES 9 D 147 PRO VAL ASP LEU LYS LYS ILE THR ASN PHE PHE ARG GLY
SEQRES 10 D 147 ASP ARG CYS ARG SER LEU THR GLY LYS PRO LYS LEU PHE
SEQRES 11 D 147 ILE ILE GLN ALA CYS ARG GLY THR GLU LEU ASP CYS GLY
SEQRES 12 D 147 ILE GLU THR ASP
SEQRES 1 E 102 SER GLY VAL ASP ASP ASP MET ALA CYS HIS LYS ILE PRO
SEQRES 2 E 102 VAL GLU ALA ASP PHE LEU TYR ALA TYR SER THR ALA PRO
SEQRES 3 E 102 GLY TYR TYR SER TRP ARG ASN SER LYS ASP GLY SER TRP
SEQRES 4 E 102 PHE ILE GLN SER LEU CYS ALA MET LEU LYS GLN TYR ALA
SEQRES 5 E 102 ASP LYS LEU GLU PHE MET HIS ILE LEU THR ARG VAL ASN
SEQRES 6 E 102 ARG LYS VAL ALA THR GLU PHE GLU SER PHE SER PHE ASP
SEQRES 7 E 102 ALA THR PHE HIS ALA LYS LYS GLN ILE PRO CYS ILE VAL
SEQRES 8 E 102 SER MET LEU THR LYS GLU LEU TYR PHE TYR HIS
HET 0ZZ A 551 36
HET 0ZZ D 551 36
HETNAM 0ZZ 5-S-BENZYL-3-({N-[(5-BROMO-2-METHOXYPHENYL)ACETYL]-L-
HETNAM 2 0ZZ VALYL}AMINO)-2,3-DIDEOXY-5-THIO-D-ERYTHRO-PENTONIC
HETNAM 3 0ZZ ACID
FORMUL 5 0ZZ 2(C26 H33 BR N2 O6 S)
HELIX 1 1 HIS A 174 GLY A 175C 5 5
HELIX 2 2 GLY A 181 PHE A 193 1 13
HELIX 3 3 ARG A 194 LYS A 197 5 4
HELIX 4 4 THR A 207 LYS A 220 1 14
HELIX 5 5 LEU A 258 ASN A 263 1 6
HELIX 6 6 PHE A 264 ARG A 266 5 3
HELIX 7 7 SER B 347 TYR B 360 1 14
HELIX 8 8 PHE B 366 THR B 379 1 14
HELIX 9 9 ASP B 381E HIS B 381I 5 5
HELIX 10 10 HIS D 174 GLY D 175C 5 5
HELIX 11 11 GLY D 181 PHE D 193 1 13
HELIX 12 12 ARG D 194 LYS D 197 5 4
HELIX 13 13 THR D 207 LYS D 220 1 14
HELIX 14 14 LEU D 258 ASN D 263 1 6
HELIX 15 15 PHE D 264 ARG D 266 5 3
HELIX 16 16 SER E 347 TYR E 360 1 14
HELIX 17 17 PHE E 366 THR E 379 1 14
HELIX 18 18 ASP E 381E HIS E 381I 5 5
SHEET 1 A12 LYS A 203 ASN A 204 0
SHEET 2 A12 ILE A 168 ASN A 169 1 N ASN A 169 O LYS A 203
SHEET 3 A12 LEU A 234 LEU A 235 1 O LEU A 235 N ILE A 168
SHEET 4 A12 LYS A 278 GLN A 283 1 O ILE A 281 N LEU A 234
SHEET 5 A12 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280
SHEET 6 A12 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329
SHEET 7 A12 CYS E 388 SER E 392 -1 O ILE E 389 N SER B 392
SHEET 8 A12 PHE E 327 TYR E 331 -1 N TYR E 329 O VAL E 390
SHEET 9 A12 LYS D 278 GLN D 283 1 N PHE D 280 O LEU E 328
SHEET 10 A12 LEU D 234 LEU D 235 1 N LEU D 234 O ILE D 281
SHEET 11 A12 ILE D 168 ASN D 169 1 N ILE D 168 O LEU D 235
SHEET 12 A12 LYS D 203 ASN D 204 1 O LYS D 203 N ASN D 169
SHEET 1 B 8 PHE A 230 VAL A 231 0
SHEET 2 B 8 LYS A 278 GLN A 283 1 O LEU A 279 N PHE A 230
SHEET 3 B 8 PHE B 327 TYR B 331 1 O LEU B 328 N PHE A 280
SHEET 4 B 8 CYS B 388 SER B 392 -1 O VAL B 390 N TYR B 329
SHEET 5 B 8 CYS E 388 SER E 392 -1 O ILE E 389 N SER B 392
SHEET 6 B 8 PHE E 327 TYR E 331 -1 N TYR E 329 O VAL E 390
SHEET 7 B 8 LYS D 278 GLN D 283 1 N PHE D 280 O LEU E 328
SHEET 8 B 8 PHE D 230 VAL D 231 1 N PHE D 230 O LEU D 279
SHEET 1 C 2 ILE A 242 PHE A 244 0
SHEET 2 C 2 PRO A 255 ASP A 257 -1 O VAL A 256 N ILE A 243
SHEET 1 D 2 GLY A 287 GLU A 289 0
SHEET 2 D 2 GLY B 336 TYR B 337 1 O GLY B 336 N GLU A 289
SHEET 1 E 2 ILE D 242 PHE D 244 0
SHEET 2 E 2 PRO D 255 ASP D 257 -1 O VAL D 256 N ILE D 243
SHEET 1 F 2 GLY D 287 GLU D 289 0
SHEET 2 F 2 GLY E 336 TYR E 337 1 O GLY E 336 N GLU D 289
LINK SG CYS A 285 C9 0ZZ A 551 1555 1555 1.81
LINK SG CYS D 285 C9 0ZZ D 551 1555 1555 1.81
SITE 1 AC1 13 ARG A 179 SER A 236 HIS A 237 GLY A 238
SITE 2 AC1 13 GLU A 239 PHE A 244 CYS A 285 TYR B 338
SITE 3 AC1 13 SER B 339 TRP B 340 ARG B 341 SER B 381A
SITE 4 AC1 13 PHE B 381B
SITE 1 AC2 13 ARG D 179 SER D 236 HIS D 237 GLY D 238
SITE 2 AC2 13 GLU D 239 PHE D 244 CYS D 285 TYR E 338
SITE 3 AC2 13 SER E 339 TRP E 340 ARG E 341 SER E 381A
SITE 4 AC2 13 PHE E 381B
CRYST1 110.300 96.900 70.900 90.00 128.06 90.00 C 1 2 1 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009066 0.000000 0.007099 0.00000
SCALE2 0.000000 0.010320 0.000000 0.00000
SCALE3 0.000000 0.000000 0.017913 0.00000
MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1
MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1
MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1
MTRIX1 2 0.227930 -0.007849 0.973646 -47.63420 1
MTRIX2 2 -0.007261 -0.999953 -0.006361 16.08090 1
MTRIX3 2 0.973651 -0.005619 -0.227976 60.25840 1